ABAMUNE-L
Brand:
ABAMUNE-L
Manufacturer:
CIPLA
Manufacturer Details
CIPLA
Compositions:
Abacavir 600mg+ Lamivudine 300mg tablets,
Strength
|
Rate
|
Packing Style
|
600mg+300mg
|
2778.38
|
30s tablets
|
List of Related Indications:
List Of Drugs:
- Abacavir sulfate/ Lamivudine - Antiviral Agents
Indication Type Description:
Indication:
HIV infection
Dosages/ Overdosage Etc:
Indication-
HIV infection
Dosage-
Adults- 1 tablet daily in combination with other antiretroviral agents.
May be taken with or without food
Dose adjustment - because it is a fixed dose tablet, abacavir/lamivudine should not be
prescribed to patients requiring dosage adjstments such as those with creatinine
clearance CrCl of less than 50mL/min. those with hepatic impairment or those experiencing
dose-limiting adverse reactions.
Use of lamivudine oral solution and abacavir oral solution may be considered
Interaction with Food:
May be taken with or without food